Not all sufferers with CLL require therapy. Even with all current advancements, the iwCLL nevertheless suggests watchful observation for people with asymptomatic illness.86 This advice is predicated on a minimum of two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 The two trials concluded https://wendellg207biq4.webdesign96.com/profile